Retatrutide has emerged as a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By boosting these receptors, Retatrutide controls cravings, {promotesglucose regulation, and ultimately contributes to significant slimming. While furthe